HSPA5 and retinitis pigmentosa: In addition, in 2017, Kang et al. [51] evaluated the efficacy of sulforaphane in the treatment of retinitis pigmentosa using mouse models, demonstrating the efficacy of sulforaphane in reducing retinitis pigmentosa by suppressing GRP78 expression, thereby reducing photoreceptor apoptosis [51].